[Federal Register: August 6, 2008 (Volume 73, Number 152)]
[Notices]               
[Page 45785]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr06au08-95]                         

-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

 
Manufacturer of Controlled Substances; Notice of Application

    Pursuant to Sec.  1301.33(a) of Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on June 11, 2008, American 
Radiolabeled Chemical, Inc., 101 Arc Drive, St. Louis, Missouri 63146, 
made application by renewal to the Drug Enforcement Administration 
(DEA) as a bulk manufacturer of the basic classes of controlled 
substances listed in schedules I and II:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Gamma hydroxybutyric acid (2010)............  I
Ibogaine (7260).............................  I
Lysergic acid diethylamide (7315)...........  I
Tetrahydrocannabinols (7370)................  I
Dimethyltryptamine (7435)...................  I
1-[1-(2-Thienyl)cyclohexyl]piper- idine       I
 (7470).
Dihydromorphine (9145)......................  I
Normorphine (9313)..........................  I
Amphetamine (1100)..........................  II
Methamphetamine (1105)......................  II
Amobarbital (2125)..........................  II
Phencyclidine (7471)........................  II
Phenylacetone (8501)........................  II
Cocaine (9041)..............................  II
Codeine (9050)..............................  II
Dihydrocodeine (9120).......................  II
Oxycodone (9143)............................  II
Hydromorphone (9150)........................  II
Ecgonine (9180).............................  II
Hydrocodone (9193)..........................  II
Meperidine (9230)...........................  II
Metazocine (9240)...........................  II
Dextropropoxyphene, bulk (non-dosage forms)   II
 (9273).
Morphine (9300).............................  II
Oripavine (9330)............................  II
Thebaine (9333).............................  II
Oxymorphone (9652)..........................  II
Phenazocine (9715)..........................  II
Fentanyl (9801).............................  II
------------------------------------------------------------------------

    The company plans to manufacture small quantities of the listed 
controlled substances as radiolabeled compounds for biochemical 
research.
    Any other such applicant, and any person who is presently 
registered with DEA to manufacture such substances, may file comments 
or objections to the issuance of the proposed registration pursuant to 
21 CFR 1301.33(a).
    Any such written comments or objections should be addressed, in 
quintuplicate, to the Drug Enforcement Administration, Office of 
Diversion Control, Federal Register Representative (ODL), 8701 
Morrissette Drive, Springfield, Virginia 22152; and must be filed no 
later than October 6, 2008.

    Dated: July 29, 2008.
 Joseph T. Rannazzisi,
 Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. E8-17971 Filed 8-5-08; 8:45 am]

BILLING CODE 4410-09-P